Interplay between dioxin-mediated signaling and circadian clock: A possible determinant in metabolic homeostasis

International Journal of Molecular Sciences

Volumn 15, Issue 7, 2014, Pages 11700-11712

  Wang, Chun ^a   Zhang, Zhi Ming ^b   Xu, Can Xin ^a   Tischkau, Shelley A ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b THE FIRST PEOPLE S HOSPITAL OF CHENZHOU   (China)

Author keywords

Aryl hydrocarbon receptor; Circadian clock; Dioxin

Indexed keywords

2, 3, 7, 8 TETRACHLORODIBENZO PARA DIOXIN; AROMATIC HYDROCARBON RECEPTOR; BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; CIRCADIAN RHYTHM SIGNALING PROTEIN; CRYPTOCHROME 1; CRYPTOCHROME 2; CYTOCHROME P450 1A1; CYTOCHROME P450 1B1; DIOXIN; DRUG METABOLIZING ENZYME; GONADORELIN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; HYPOXIA INDUCIBLE FACTOR 1BETA; MESSENGER RNA; NUCLEAR RECEPTOR NR1D1; PER1 PROTEIN; PER2 PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PROTEIN BMAL1; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR CLOCK; UNCLASSIFIED DRUG;

CIRCADIAN RHYTHM; E BOX ELEMENT; FEEDBACK SYSTEM; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; METABOLIC DISORDER; MOLECULAR INTERACTION; NEOPLASM; NONHUMAN; PHYSIOLOGY; POLLUTANT; PROTEIN EXPRESSION; PROTEIN HOMEOSTASIS; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; SLEEP DISORDER; SUPRACHIASMATIC NUCLEUS; ANIMAL; ENVIRONMENTAL ILLNESS; HOMEOSTASIS; METABOLISM; TOXICITY;

ANIMALS; CIRCADIAN CLOCKS; DIOXINS; ENVIRONMENTAL ILLNESS; HOMEOSTASIS; HUMANS; RECEPTORS, ARYL HYDROCARBON; SIGNAL TRANSDUCTION;

EID: 84903744439     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms150711700     Document Type: Review

References (72)

1. Rey, G.; Reddy, A.B. Connecting cellular metabolism to circadian clocks. Trends Cell Biol. 2013, 23, 234-241.
2. Eckel-Mahan, K.; Sassone-Corsi, P. Metabolism and the circadian clock converge. Physiol. Rev. 2013, 93, 107-135.
3. Zelinski, E.L.; Deibel, S.H.; McDonald, R.J. The trouble with circadian clock dysfunction: Multiple deleterious effects on the brain and body. Neurosci. Biobehav. Rev. 2014, 40C, 80-101.
4. Sahar, S.; Sassone-Corsi, P. Metabolism and cancer: The circadian clock connection. Nat. Rev. Cancer 2009, 9, 886-896.
5. Diamanti-Kandarakis, E.; Bourguignon, J.P.; Giudice, L.C.; Hauser, R.; Prins, G.S.; Soto, A.M.; Zoeller, R.T.; Gore, A.C. Endocrine-disrupting chemicals: An Endocrine Society scientific statement. Endocr. Rev. 2009, 30, 293-342.
6. Soto, A.M.; Sonnenschein, C. Environmental causes of cancer: Endocrine disruptors as carcinogens. Nat. Rev. Endocrinol. 2010, 6, 363-370.
7. Thayer, K.A.; Heindel, J.J.; Bucher, J.R.; Gallo, M.A. Role of environmental chemicals in diabetes and obesity: A National Toxicology Program workshop review. Environ. Health Perspect. 2012, 120, 779-789.
8. Gu, Y.Z.; Hogenesch, J.B.; Bradfield, C.A. The PAS superfamily: Sensors of environmental and developmental signals. Annu. Rev. Pharmacol. Toxicol. 2000, 40, 519-561.
9. McIntosh, B.E.; Hogenesch, J.B.; Bradfield, C.A. Mammalian Per-Arnt-Sim proteins in environmental adaptation. Annu. Rev. Physiol. 2010, 72, 625-645.
10. Denison, M.S.; Soshilov, A.A.; He, G.; DeGroot, D.E.; Zhao, B. Exactly the same but different: Promiscuity and diversity in the molecular mechanisms of action of the aryl hydrocarbon (dioxin) receptor. Toxicol. Sci. 2011, 124, 1-22.
11. Anderson, G.; Beischlag, T.V.; Vinciguerra, M.; Mazzoccoli, G. The circadian clock circuitry and the AHR signaling pathway in physiology and pathology. Biochem. Pharmacol. 2013, 85, 1405-1416.
12. Shimba, S.; Watabe, Y. Crosstalk between the AHR signaling pathway and circadian rhythm. Biochem. Pharmacol. 2009, 77, 560-565.
13. Qu, X.; Metz, R.P.; Porter, W.W.; Cassone, V.M.; Earnest, D.J. Disruption of clock gene expression alters responses of the aryl hydrocarbon receptor signaling pathway in the mouse mammary gland. Mol. Pharmacol. 2007, 72, 1349-1358.
14. Qu, X.; Metz, R.P.; Porter, W.W.; Neuendorff, N.; Earnest, B.J.; Earnest, D.J. The clock genes period 1 and period 2 mediate diurnal rhythms in dioxin-induced Cyp1A1 expression in the mouse mammary gland and liver. Toxicol. Lett. 2010, 196, 28-32.
15. Partch, C.L.; Green, C.B.; Takahashi, J.S. Molecular architecture of the mammalian circadian clock. Trends Cell Biol. 2014, 24, 90-99.
16. Dibner, C.; Schibler, U.; Albrecht, U. The mammalian circadian timing system: Organization and coordination of central and peripheral clocks. Annu. Rev. Physiol. 2010, 72, 517-549.
17. Boulos, Z.; Terman, M. Food availability and daily biological rhythms. Neurosci. Biobehav. Rev. 1980, 4, 119-131.
18. Mistlberger, R.E. Circadian food-anticipatory activity: Formal models and physiological mechanisms. Neurosci. Biobehav. Rev. 1994, 18, 171-195.
19. Stephan, F.K. The "other" circadian system: Food as a Zeitgeber. J. Biol. Rhythm. 2002, 17, 284-292.
20. Brown, S.A.; Zumbrunn, G.; Fleury-Olela, F.; Preitner, N.; Schibler, U. Rhythms of mammalian body temperature can sustain peripheral circadian clocks. Curr. Biol. 2002, 12, 1574-1583.
21. Mendoza, J. Circadian clocks: Setting time by food. J. Neuroendocrinol. 2007, 19, 127-137.
22. Langner, R.; Rensing, L. Circadian rhythm of oxygen consumption in rat liver suspension culture: Changes of pattern. Z. Naturforschung Teil B 1972, 27, 1117-1118.
23. Yoo, S.H.; Yamazaki, S.; Lowrey, P.L.; Shimomura, K.; Ko, C.H.; Buhr, E.D.; Siepka, S.M.; Hong, H.K.; Oh, W.J.; Yoo, O.J.; et al. PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues. Proc. Natl. Acad. Sci. USA 2004, 101, 5339-5346.
24. Richards, J.; Gumz, M.L. Mechanism of the circadian clock in physiology. Am. J. Physiol. 2013, 304, R1053-R1064.
25. Gekakis, N.; Staknis, D.; Nguyen, H.B.; Davis, F.C.; Wilsbacher, L.D.; King, D.P.; Takahashi, J.S.; Weitz, C.J. Role of the CLOCK protein in the mammalian circadian mechanism. Science 1998, 280, 1564-1569.
26. Zhang, E.E.; Kay, S.A. Clocks not winding down: Unravelling circadian networks. Nat. Rev. Mol. Cell Biol. 2010, 11, 764-776.
27. Ripperger, J.A.; Shearman, L.P.; Reppert, S.M.; Schibler, U. CLOCK, an essential pacemaker component, controls expression of the circadian transcription factor DBP. Genes Dev. 2000, 14, 679-689.
28. Jin, X.; Shearman, L.P.; Weaver, D.R.; Zylka, M.J.; de Vries, G.J.; Reppert, S.M. A molecular mechanism regulating rhythmic output from the suprachiasmatic circadian clock. Cell 1999, 96, 57-68.
29. Cheng, M.Y.; Bullock, C.M.; Li, C.; Lee, A.G.; Bermak, J.C.; Belluzzi, J.; Weaver, D.R.; Leslie, F.M.; Zhou, Q.Y. Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus. Nature 2002, 417, 405-410.
30. Oishi, K.; Shirai, H.; Ishida, N. CLOCK is involved in the circadian transactivation of peroxisome-proliferator-activated receptor alpha (PPARα) in mice. Biochem. J. 2005, 386, 575-581.
31. Canaple, L.; Rambaud, J.; Dkhissi-Benyahya, O.; Rayet, B.; Tan, N.S.; Michalik, L.; Delaunay, F.; Wahli, W.; Laudet, V. Reciprocal regulation of brain and muscle Arnt-like protein 1 and peroxisome proliferator-activated receptor α defines a novel positive feedback loop in the rodent liver circadian clock. Mol. Endocrinol. 2006, 20, 1715-1727.
32. Zhang, Y.K.; Yeager, R.L.; Klaassen, C.D. Circadian expression profiles of drug-processing genes and transcription factors in mouse liver. Drug Metab. Dispos. 2009, 37, 106-115.
33. Antoch, M.P.; Song, E.J.; Chang, A.M.; Vitaterna, M.H.; Zhao, Y.; Wilsbacher, L.D.; Sangoram, A.M.; King, D.P.; Pinto, L.H.; Takahashi, J.S. Functional identification of the mouse circadian Clock gene by transgenic BAC rescue. Cell 1997, 89, 655-667.
34. Ikeda, M.; Nomura, M. cDNA cloning and tissue-specific expression of a novel basic helix-loop-helix/PAS protein (BMAL1) and identification of alternatively spliced variants with alternative translation initiation site usage. Biochem. Biophys. Res. Commun. 1997, 233, 258-264.
35. Reddy, P.; Jacquier, A.C.; Abovich, N.; Petersen, G.; Rosbash, M. The period clock locus of D. melanogaster codes for a proteoglycan. Cell 1986, 46, 53-61.
36. Hoffman, E.C.; Reyes, H.; Chu, F.F.; Sander, F.; Conley, L.H.; Brooks, B.A.; Hankinson, O. Cloning of a factor required for activity of the Ah (dioxin) receptor. Science 1991, 252, 954-958.
37. Nambu, J.R.; Lewis, J.O.; Wharton, K.A., Jr.; Crews, S.T. The Drosophila single-minded gene encodes a helix-loop-helix protein that acts as a master regulator of CNS midline development. Cell 1991, 67, 1157-1167.
38. Itoh, S.; Kamataki, T. Human Ah receptor cDNA: Analysis for highly conserved sequences. Nucleic Acids Res. 1993, 21, 3578.
39. Takahata, S.; Sogawa, K.; Kobayashi, A.; Ema, M.; Mimura, J.; Ozaki, N.; Fujii-Kuriyama, Y. Transcriptionally active heterodimer formation of an Arnt-like PAS protein, Arnt3, with HIF-1a, HLF, and Clock. Biochem. Biophys. Res. Commun. 1998, 248, 789-794.
40. Xu, C.X.; Krager, S.L.; Liao, D.F.; Tischkau, S.A. Disruption of CLOCK-BMAL1 transcriptional activity is responsible for aryl hydrocarbon receptor-mediated regulation of Period1 gene. Toxicol. Sci. 2010, 115, 98-108.
41. Hogenesch, J.B.; Gu, Y.Z.; Jain, S.; Bradfield, C.A. The basic-helix-loop-helix-PAS orphan MOP3 forms transcriptionally active complexes with circadian and hypoxia factors. Proc. Natl. Acad. Sci. USA 1998, 95, 5474-5479.
42. Abbott, B.D.; Birnbaum, L.S.; Perdew, G.H. Developmental expression of two members of a new class of transcription factors: I. Expression of aryl hydrocarbon receptor in the C57BL/6N mouse embryo. Dev. Dyn. 1995, 204, 133-143.
43. Li, W.; Donat, S.; Dohr, O.; Unfried, K.; Abel, J. Ah receptor in different tissues of C57BL/6J and DBA/2J mice: Use of competitive polymerase chain reaction to measure Ah-receptor mRNA expression. Arch. Biochem. Biophys. 1994, 315, 279-284.
44. Richardson, V.M.; Santostefano, M.J.; Birnbaum, L.S. Daily cycle of bHLH-PAS proteins, Ah receptor and Arnt, in multiple tissues of female Sprague-Dawley rats. Biochem. Biophys. Res. Commun. 1998, 252, 225-231.
45. Huang, P.; Ceccatelli, S.; Rannug, A. A study on diurnal mRNA expression of CYP1A1, AHR, ARNT, and PER2 in rat pituitary and liver. Environ. Toxicol. Pharmacol. 2002, 11, 119-126.
46. Mukai, M.; Lin, T.M.; Peterson, R.E.; Cooke, P.S.; Tischkau, S.A. Behavioral rhythmicity of mice lacking AhR and attenuation of light-induced phase shift by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Biol. Rhythm. 2008, 23, 200-210.
47. Qu, X.; Metz, R.P.; Porter, W.W.; Cassone, V.M.; Earnest, D.J. Disruption of period gene expression alters the inductive effects of dioxin on the AhR signaling pathway in the mouse liver. Toxicol. Appl. Pharmacol. 2009, 234, 370-377.
48. Tanimura, N.; Kusunose, N.; Matsunaga, N.; Koyanagi, S.; Ohdo, S. Aryl hydrocarbon receptor-mediated Cyp1a1 expression is modulated in a CLOCK-dependent circadian manner. Toxicology 2011, 290, 203-207.
49. Garrison, P.M.; Denison, M.S. Analysis of the murine AhR gene promoter. J. Biochem. Mol. Toxicol. 2000, 14, 1-10.
50. Xu, C.X.; Wang, C.; Krager, S.L.; Bottum, K.M.; Tischkau, S.A. Aryl hydrocarbon receptor activation attenuates Per1 gene induction and influences circadian clock resetting. Toxicol. Sci. 2013, 132, 368-378.
51. Mukai, M.; Tischkau, S.A. Effects of tryptophan photoproducts in the circadian timing system: Searching for a physiological role for aryl hydrocarbon receptor. Toxicol. Sci. 2007, 95, 172-181.
52. Solak, K.A.; Wijnolts, F.M.; Pralong, F.P.; Blaauboer, B.J.; van den Berg, M.; Westerink, R.H.; van Duursen, M.B. In vitro neuroendocrine effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the AhR-expressing hypothalamic rat GnV-3 cell line. Toxicology 2013, 311, 124-134.
53. Sato, S.; Shirakawa, H.; Tomita, S.; Ohsaki, Y.; Haketa, K.; Tooi, O.; Santo, N.; Tohkin, M.; Furukawa, Y.; Gonzalez, F.J.; et al. Low-dose dioxins alter gene expression related to cholesterol biosynthesis, lipogenesis, and glucose metabolism through the aryl hydrocarbon receptor-mediated pathway in mouse liver. Toxicol. Appl. Pharmacol. 2008, 229, 10-19.
54. Tischkau, S.A.; Jaeger, C.D.; Krager, S.L. Circadian clock disruption in the mouse ovary in response to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Lett. 2011, 201, 116-122.
55. Garrett, R.W.; Gasiewicz, T.A. The aryl hydrocarbon receptor agonist 2,3,7,8-tetrachlorodibenzop-dioxin alters the circadian rhythms, quiescence, and expression of clock genes in murine hematopoietic stem and progenitor cells. Mol. Pharmacol. 2006, 69, 2076-2083.
56. Malik, A.I.; Rowan-Carroll, A.; Williams, A.; Lemieux, C.L.; Long, A.S.; Arlt, V.M.; Phillips, D.H.; White, P.A.; Yauk, C.L. Hepatic genotoxicity and toxicogenomic responses in MutaMouse males treated with dibenz[a, h]anthracene. Mutagenesis 2013, 28, 543-554.
57. Pendergast, J.S.; Yamazaki, S. The mammalian circadian system is resistant to dioxin. J. Biol. Rhythm. 2012, 27, 156-163.
58. Wang, C.; Xu, C.X.; Krager, S.L.; Bottum, K.M.; Liao, D.F.; Tischkau, S.A. Aryl hydrocarbon receptor deficiency enhances insulin sensitivity and reduces PPAR-α pathway activity in mice. Environ. Health Perspect. 2011, 119, 1739-1744.
59. Kelling, C.K.; Christian, B.J.; Inhorn, S.L.; Peterson, R.E. Hypophagia-induced weight loss in mice, rats, and guinea pigs treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundam. Appl. Toxicol. 1985, 5, 700-712.
60. Seefeld, M.D.; Corbett, S.W.; Keesey, R.E.; Peterson, R.E. Characterization of the wasting syndrome in rats treated with 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 1984, 73, 311-322.
61. Jones, M.K.; Weisenburger, W.P.; Sipes, I.G.; Russell, D.H. Circadian alterations in prolactin, corticosterone, and thyroid hormone levels and down-regulation of prolactin receptor activity by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 1987, 87, 337-350.
62. Pohjanvirta, R.; Tuomisto, J.; Linden, J.; Laitinen, J. TCDD reduces serum melatonin levels in Long-Evans rats. Pharmacol. Toxicol. 1989, 65, 239-240.
63. Yellon, S.M.; Singh, D.; Garrett, T.M.; Fagoaga, O.R.; Nehlsen-Cannarella, S.L. Reproductive, neuroendocrine, and immune consequences of acute exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in the Siberian hamster. Biol. Reprod. 2000, 63, 538-543.
64. Gentner, N.J.; Weber, L.P. Intranasal benzo[a]pyrene alters circadian blood pressure patterns and causes lung inflammation in rats. Arch. Toxicol. 2011, 85, 337-346.
65. Dugo, M.A.; Han, F.; Tchounwou, P.B. Persistent polar depletion of stratospheric ozone and emergent mechanisms of ultraviolet radiation-mediated health dysregulation. Rev. Environ. Health 2012, 27, 103-116.
66. Ma, Q. Influence of light on aryl hydrocarbon receptor signaling and consequences in drug metabolism, physiology and disease. Expert Opin. Drug Metab. Toxicol. 2011, 7, 1267-1293.
67. Arisawa, K.; Takeda, H.; Mikasa, H. Background exposure to PCDDs/PCDFs/PCBs and its potential health effects: A review of epidemiologic studies. J. Med. Investig. 2005, 52, 10-21.
68. Bertazzi, P.A.; Bernucci, I.; Brambilla, G.; Consonni, D.; Pesatori, A.C. The Seveso studies on early and long-term effects of dioxin exposure: A review. Environ. Health Perspect. 1998, 106, 625-633.
69. Larsen, J.C. Risk assessments of polychlorinated dibenzo-p-dioxins, polychlorinated dibenzofurans, and dioxin-like polychlorinated biphenyls in food. Mol. Nutr. Food Res. 2006, 50, 885-896.
70. Henriksen, G.L.; Ketchum, N.S.; Michalek, J.E.; Swaby, J.A. Serum dioxin and diabetes mellitus in veterans of Operation Ranch Hand. Epidemiology 1997, 8, 252-258.
71. Cui, J.; Li, S. Inhibitors and prodrugs targeting CYP1: A novel approach in cancer prevention and therapy. Curr. Med. Chem. 2014, 21, 519-552.
72. Korkina, L.G.; Pastore, S.; Dellambra, E.; de Luca, C. New molecular and cellular targets for chemoprevention and treatment of skin tumors by plant polyphenols: A critical review. Curr. Med. Chem. 2013, 20, 852-868.